News & Updates

Co-occurrence of serious illnesses common in old age, ups healthcare utilization

16 Jun 2022

Some 40 percent of older adults seem to have multiple concomitant diagnoses for serious illnesses, a recent study has found. Such co-occurrence in turn increases their risk of healthcare utilization at the end of life.

Co-occurrence of serious illnesses common in old age, ups healthcare utilization

16 Jun 2022

Expectant moms with low vitamin D levels at risk of miscarriage

16 Jun 2022 by

Pregnant women with vitamin D deficiency run the risk of losing their foetuses in the womb, according to a meta-analysis.

Expectant moms with low vitamin D levels at risk of miscarriage

16 Jun 2022

Dostarlimab a miraculous cure for mismatch repair-deficient, locally advanced rectal cancer?

16 Jun 2022

Use of dostarlimab, a single-agent programmed death 1 (PD-1) monoclonal antibody, appears to have successfully cured mismatch repair-deficient, locally advanced rectal cancer, reports a recent study.

Dostarlimab a miraculous cure for mismatch repair-deficient, locally advanced rectal cancer?

16 Jun 2022

Dyspnoea may elevate stress in artificial stone benchtop industry workers

16 Jun 2022 by

Dyspnoea is associated with higher perceived stress in silica-exposed workers from the artificial stone benchtop industry at risk of silicosis, a permanent but preventable lung disease, suggests a study.

Dyspnoea may elevate stress in artificial stone benchtop industry workers

16 Jun 2022

How effective are contraceptive counseling, provision interventions for women?

16 Jun 2022

Contraceptive counseling and provision of services beyond usual care are both effective at improving contraceptive use without increasing sexually transmitted infections (STIs) or reducing condom use, results of a systematic review and meta-analysis have shown.

How effective are contraceptive counseling, provision interventions for women?

16 Jun 2022

EMPRISE shows CV efficacy, safety of empagliflozin in routine care

16 Jun 2022 by

The final analysis of the 5-year monitoring EMPRISE* programme presented at ADA 2022 demonstrated the cardiovascular (CV) efficacy of empagliflozin in patients with type 2 diabetes (T2D), with a safety profile that aligns with existing evidence.

EMPRISE shows CV efficacy, safety of empagliflozin in routine care

16 Jun 2022

Infertility treatments tied to developmental delays at age 2 years

16 Jun 2022 by

Infants conceived with the help of infertility treatments, such as ovulation induction (OI) and artificial insemination with the husband’s sperm (AIH), are more likely to experience developmental delays at 2 years of age, according to a recent Japan study. However, such delays appear to grow nonsignificant by 3.5 years of age.

Infertility treatments tied to developmental delays at age 2 years

16 Jun 2022

Concomitant insulin may counter renoprotective effects of SGLT2is in T2D patients with CKD

16 Jun 2022

Renal composite outcomes (RCO) appear to be less favourable among type 2 diabetes (T2D) patients with chronic kidney disease (CKD) treated with insulin and sodium-glucose cotransporter 2 inhibitors (SGLT2i), a recent Japan study has found.

Concomitant insulin may counter renoprotective effects of SGLT2is in T2D patients with CKD

16 Jun 2022

JAK inhibition with upadacitinib works well in nr-axSpA

16 Jun 2022 by

Treatment with upadacitinib improves disease activity, pain, function, and quality of life (QoL) in patients with non-radiographic axial spondyloarthritis (nr-axSpA) in a study touted as the first to evaluate a Janus kinase (JAK) inhibitor for this condition.

JAK inhibition with upadacitinib works well in nr-axSpA

16 Jun 2022

Fixed-dose albuterol/budesonide an effective rescue med in moderate-to-severe asthma

15 Jun 2022 by

A fixed-dose combination of albuterol and budesonide, delivered as needed, reduced the risk of severe exacerbations in patients with moderate-to-severe asthma inadequately controlled with corticosteroid maintenance therapy, according to results of the phase III MANDALA trial presented at ATS 2022.

Fixed-dose albuterol/budesonide an effective rescue med in moderate-to-severe asthma

15 Jun 2022

News & Updates

Filter by Specialty:

Specialty:

Co-occurrence of serious illnesses common in old age, ups healthcare utilization

Co-occurrence of serious illnesses common in old age, ups healthcare utilization

Expectant moms with low vitamin D levels at risk of miscarriage

Expectant moms with low vitamin D levels at risk of miscarriage

Dostarlimab a miraculous cure for mismatch repair-deficient, locally advanced rectal cancer?

Dostarlimab a miraculous cure for mismatch repair-deficient, locally advanced rectal cancer?

Dyspnoea may elevate stress in artificial stone benchtop industry workers

Dyspnoea may elevate stress in artificial stone benchtop industry workers

How effective are contraceptive counseling, provision interventions for women?

How effective are contraceptive counseling, provision interventions for women?

EMPRISE shows CV efficacy, safety of empagliflozin in routine care

EMPRISE shows CV efficacy, safety of empagliflozin in routine care

Infertility treatments tied to developmental delays at age 2 years

Infertility treatments tied to developmental delays at age 2 years

Concomitant insulin may counter renoprotective effects of SGLT2is in T2D patients with CKD

Concomitant insulin may counter renoprotective effects of SGLT2is in T2D patients with CKD

JAK inhibition with upadacitinib works well in nr-axSpA

JAK inhibition with upadacitinib works well in nr-axSpA

Fixed-dose albuterol/budesonide an effective rescue med in moderate-to-severe asthma

Fixed-dose albuterol/budesonide an effective rescue med in moderate-to-severe asthma